Medtronic plc (MDT) : The total money flow in Medtronic plc (MDT) was negative ($3.5 million), showing the domination of sellers in the Wednesday trading session. The traders utilized every rise to sell their positions, as seen in the value of trading on downtick to the tune of $33.5 million. Transactions on upticks were comparatively lower at $30 million. The uptick to downtick ratio was 0.9. The total block trades on downticks were valued at $3.73 million. The money flow during block trades was negative ($3.73 million) when the stock traded with a gain of $3 cent. Medtronic plc (MDT) was $86.7, an increase of 0.03% over the previous days close.
Medtronic plc has lost 0.46% in the last five trading days and dropped 0.82% in the last 4 weeks. Medtronic plc is up 2.01% in the last 3-month period. Year-to-Date the stock performance stands at 13.9%.
Medtronic plc (MDT) : 12 brokerage houses believe that Medtronic plc (MDT) is a Strong Buy at current levels. 2 Analyst considers the fundamentals to be worthy of a Buy recommendation. 5 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Medtronic plc (MDT). Zacks Investment Research suggests a Hold with a rank of 3. 1 others believe that the stock has run up ahead of its fundamentals and advise a Strong Sell on the stock.The median of all the 20 Wall Street Analysts endorse the stock as a Buy with a rating of 1.78.
Medtronic plc (NYSE:MDT): The stock opened at $86.56 and touched an intraday high of $86.89 on Wednesday. During the day, the stock corrected to an intraday low of $86.16, however, the bulls stepped in and pushed the price higher to close in the green at $86.74 with a gain of 0.08% for the day. The total traded volume for the day was 3,208,101. The stock had closed at $86.67 in the previous trading session.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.